Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Gallbladder Neoplasms 1 Feeding Behavior 1 Cholangiocarcinoma 1 Bone Neoplasms 1

Interventions

Methotrexate 21 Ifosfamide 21 Cyclophosphamide 19 Doxorubicin 17 Cisplatin 14 Filgrastim 13 Gemcitabine 12 Etoposide 11 Leucovorin 9 apatinib 8 fludarabine 7 glucarpidase 6 Vincristine 6 Temozolomide 6 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Carboplatin 6 regorafenib 5 cabozantinib 5 Zoledronic Acid 5 Topotecan 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 pembrolizumab 4 pegfilgrastim 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × Microbiota × Clear all

NCT04735289 2023-08-04

Metabol-Sarc

Istituto Ortopedico Rizzoli

Bone Neoplasms, Feeding Behavior, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡